Even though Advair’s main patent expired in 2010 and the patent on the Diskus inhaler expired in 2016, until now no-one has managed to get the FDA to approve a cheaper copy of the drug-device ...

Corticosteroid + long-acting beta-2 agonist (LABA). Allow approx. 12hrs between doses. Asthma: ≥12yrs: initially 1 inh of 100/50 or 250/50 or 500/50 twice daily, based on disease severity and ...

GlaxoSmithKline has confirmed it will face a challenging 2019 as generics of its big-selling Advair drug finally reach the US, as it continues the transformation of its business. The FDA approved ...

and of concomitant disease or other drug therapy. In addition, as with other products containing beta 2-agonists, special caution should be observed when using Advair HFA in geriatric patients who ...

A Minnesota mom will spend less than four years in prison after pleading guilty to manslaughter after she and her husband ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is ... inhaled corticosteroid medication for a short period.

which have prevented key drug approvals so far. Looking ahead, Cipla aims to file its generic Advair product application from an alternative site by mid-FY 2025, which could gain approval towards ...